These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34076486)

  • 1. Prior Heterologous Flavivirus Exposure Results in Reduced Pathogenesis in a Mouse Model of Zika Virus Infection.
    Hassert M; Steffen TL; Scroggins S; Coleman AK; Shacham E; Brien JD; Pinto AK
    J Virol; 2021 Jul; 95(16):e0057321. PubMed ID: 34076486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
    Elong Ngono A; Shresta S
    Front Immunol; 2019; 10():1316. PubMed ID: 31244855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Schwann cells are susceptible to infection with Zika and yellow fever viruses, but not dengue virus.
    Dhiman G; Abraham R; Griffin DE
    Sci Rep; 2019 Jul; 9(1):9951. PubMed ID: 31289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different Cross-Reactivities of IgM Responses in Dengue, Zika and Tick-Borne Encephalitis Virus Infections.
    Stiasny K; Malafa S; Aberle SW; Medits I; Tsouchnikas G; Aberle JH; Holzmann H; Heinz FX
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33807442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding.
    Zimmerman MG; Wrammert J; Suthar MS
    Cell Host Microbe; 2020 Jan; 27(1):14-24. PubMed ID: 31917957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
    Sariol CA; Nogueira ML; Vasilakis N
    Trends Microbiol; 2018 Mar; 26(3):186-190. PubMed ID: 29122447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure.
    Andrade DV; Harris E
    Virus Res; 2018 Aug; 254():27-33. PubMed ID: 28655548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of Dengue, Zika, and Yellow Fever Viruses among Children in the Democratic Republic of the Congo.
    Willcox AC; Collins MH; Jadi R; Keeler C; Parr JB; Mumba D; Kashamuka M; Tshefu A; de Silva AM; Meshnick SR
    Am J Trop Med Hyg; 2018 Sep; 99(3):756-763. PubMed ID: 29988000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.
    Reynolds CJ; Suleyman OM; Ortega-Prieto AM; Skelton JK; Bonnesoeur P; Blohm A; Carregaro V; Silva JS; James EA; Maillère B; Dorner M; Boyton RJ; Altmann DM
    Sci Rep; 2018 Jan; 8(1):672. PubMed ID: 29330423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants.
    Reynolds CJ; Watber P; Santos CNO; Ribeiro DR; Alves JC; Fonseca ABL; Bispo AJB; Porto RLS; Bokea K; de Jesus AMR; de Almeida RP; Boyton RJ; Altmann DM
    Front Immunol; 2020; 11():185. PubMed ID: 32132999
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
    Malafa S; Medits I; Aberle JH; Aberle SW; Haslwanter D; Tsouchnikas G; Wölfel S; Huber KL; Percivalle E; Cherpillod P; Thaler M; Roßbacher L; Kundi M; Heinz FX; Stiasny K
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the diverse structural landscape of the flavivirus antibody repertoire.
    Sevvana M; Kuhn RJ
    Curr Opin Virol; 2020 Dec; 45():51-64. PubMed ID: 32801077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Cell Immunity and Zika Virus Vaccine Development.
    Lima NS; Rolland M; Modjarrad K; Trautmann L
    Trends Immunol; 2017 Aug; 38(8):594-605. PubMed ID: 28579320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.
    McCracken MK; Gromowski GD; Friberg HL; Lin X; Abbink P; De La Barrera R; Eckles KH; Garver LS; Boyd M; Jetton D; Barouch DH; Wise MC; Lewis BS; Currier JR; Modjarrad K; Milazzo M; Liu M; Mullins AB; Putnak JR; Michael NL; Jarman RG; Thomas SJ
    PLoS Pathog; 2017 Aug; 13(8):e1006487. PubMed ID: 28771605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.
    Yamanaka A; Matsuda M; Okabayashi T; Pitaksajjakul P; Ramasoota P; Saito K; Fukasawa M; Hanada K; Matsuura T; Muramatsu M; Shioda T; Suzuki R
    mSphere; 2021 Aug; 6(4):e0033921. PubMed ID: 34259560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.